Ken Gordon is an entrepreneur with a long history in the Alberta ICT sector. Most recently, he was founding president of Invidi Technologies Inc., a venture-backed developer of innovative software for delivering targeted television advertising. Before Invidi, Mr Gordon was the founding president of Myrias Research Corporation, a pioneering venture-backed parallel supercomputer hardware and software developer, president of Precise Systems Corporation, a document management software company that he led through ten years of bootstrapped growth, and involved with Jade Simulations International, a venture-backed parallel software company that had been spun out of the University of Calgary. Lately, he has turned his attention to helping early stage technology startups deal with the problems of planning, establishing and financing. Ken is also the Chairman of THECIS, the Centre for Innovation Studies.

Brian Barge is President and CEO of CMC Microsystems. Prior to CMC, Brian was President and CEO of the Ottawa Economic Development Corporation where he played a leadership role in the development of Ottawa’s high technology industry. Before that he was President and CEO of the Alberta Research Council, one of Canada’s premier R&D organizations.

Brian began his career as a scientist at the Alberta Research Council working in advanced radar systems, and subsequently led research and development in areas such as atmospheric sciences, intelligent systems, energy, and biotechnology.

Throughout his career, Brian has worked to stimulate the creation and growth of technology-intensive companies, and to develop innovative partnerships among companies, universities, non-profits and governments in many areas strategic to Canada’s future.

Brian holds Doctoral and Master’s degrees from McGill University and a Bachelor’s degree from the University of Saskatchewan.
www.cmc.ca

Mr Massey joined CTI in early 2006 as Vice President, Innovation and Commercialization. He is responsible for managing CTI’s operations, the design and delivery of CTI’s client innovation and commercialization programs and securing and sustaining public and private program funding.

Before joining CTI, Mr Massey was Client Financing Director at Inno-centre Alberta, a business incubator for the ICT and Life Sciences industries. There, he was responsible for identifying viable new ventures, providing executive coaching, and matching ventures with professional business services and sources of financing. Previously, Mr Massey was Investment Manager of a Calgary-based private equity venture capital fund where he managed an investment portfolio of emerging public and private technology ventures. Prior to that, Mr Massey held various positions with TELUS, most recently as Assistant Vice President and General Manager of e-business services, including application hosting, audio and video conferencing, and e-commerce services.

Mr Massey has a BSc in Electrical Engineering (Computing) and an MBA in New Venture Development, both from the University of Calgary.
www.calgarytechnologies.com

Dr Adachi joined the technology transfer office at the University of Alberta in Edmonton in 1995 as a technology manager responsible for health sciences technology. He is currently managing Technology Transfer Division at the newly formed TEC Edmonton, a joint venture between the University of Alberta and Edmonton Economic Development Corporation (EEDC).

Before joining the technology transfer office of the University of Alberta, Dr Adachi worked in the pharmaceutical industry for seven years in Edmonton area as a researcher and then a research administrator. He was Director of Research Administration (Biology) at SynPhar Laboratories, Inc., a pharmaceutical research company. More recently he was Vice President of Janus Pharmaceuticals, Inc. Previous to working in the pharmaceutical industry he was Assistant Professor of Biochemistry at the University of Saskatchewan.

Dr Adachi obtained his BSc in Biology in Japan and PhD in Biochemistry in Canada. He is a member of the Association of University Technology Managers (AUTM) and the Licensing Executives Society (LES) and has given many presentations and lectures on technology transfer-related subject internationally.
www.tecedmonton.com

Kevin Casement joined UTI in October 2005 as Vice President of Licensing and Business Development. He came to UTI from the University of Texas, MD Anderson Cancer Center (MDACC) where he worked as their Director of Technology Assessment and Licensing. Kevin joined MDACC in 1998, and closed a number of licensing agreements while there. Prior to that, Dr Casement was a Scientific Advisor with Arnold White & Durkee, a well known Intellectual Property (IP) legal firm, where he honed his IP skills and experience. Kevin has a PhD in Biomedical Sciences with an emphasis in Cellular Immunology, from the University of Texas Health Science Center in Houston and the University of Texas MD Anderson Cancer Center. Kevin’s undergraduate work was completed at North Dakota State University.
www.uti.ca